Gemcitabine and carboplatin in patients with locally advanced or metastatic non-small cell lung cancer: a prospective phase II study-Reference-Cited by-同舟云学术

Gemcitabine and carboplatin in patients with locally advanced or metastatic non-small cell lung cancer: a prospective phase II study

Published:2003-04 Issue:1 Volume:40 Page:85-90
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Kortsik C,Albrecht P,Elmer A

Funder

Eli Lilly and Company

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference22 articles.

1. Non-small cell lung cancer;Ginsberg,1997

2. Single agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a Phase II study;Anderson;J. Clin. Oncol.,1994

3. Efficacy and safety profile of gemcitabine in advanced non-small-cell lung cancer: a phase II study;Abratt;J. Clin. Oncol.,1994

4. Activity of gemcitabine in patients with non-small-cell lung cancer: a multicenter expanded Phase II study;Gatzemeier;Eur. J. Cancer,1996

5. Carboplatin (CARBO) in combination with gemcitabine (GEM) in advanced non-small cell lung cancer (NSCLC). Comparison of two consecutive phase II trials using different schedules;Carrato;Proc. Am. Soc. Clin. Oncol.,1999

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Individual-level data on the relationships of progression-free survival and post-progression survival with overall survival in patients with advanced non-squamous non-small cell lung cancer patients who received second-line chemotherapy;Medical Oncology;2014-06-25

2. Individual-level data on the relationships of progression-free survival, post-progression survival, and tumor response with overall survival in patients with advanced non-squamous non-small cell lung cancer;Neoplasma;2014

3. Comparison of pemetrexed plus cisplatin with other first-line doublets in advanced non-small cell lung cancer (NSCLC): A combined analysis of three phase 3 trials;Lung Cancer;2012-05

4. Maintenance Bevacizumab is Associated With Increased Hemoglobin in Patients With Advanced, Nonsquamous, Non-Small Cell Lung Cancer;Cancer Investigation;2012-02-23

5. Randomized, Phase II Trial of Pemetrexed and Carboplatin with or without Enzastaurin versus Docetaxel and Carboplatin as First-Line Treatment of Patients with Stage IIIB/IV Non-small Cell Lung Cancer;Journal of Thoracic Oncology;2010-12